Publications by authors named "Helene Bayer"

Claim this Profile
R
Riproximin is a recently discovered type II ribosome inactivating protein with potential for treating cancer.
Hassan Adwan, Helene Bayer, Asim Pervaiz, Micah Sagini, Martin R Berger

Biotechnol Adv· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting.
Helene Bayer, Katharina Essig, Sven Stanzel, Martin Frank, Jeffrey C Gildersleeve

J Biol Chem· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification and characterization of riproximin from Ximenia americana fruit kernels.
Helene Bayer, Noreen Ey, Andreas Wattenberg, Cristina Voss, Martin R Berger

Protein Expr Purif· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis